JFNIX | RYCFX | JFNIX / RYCFX | |
Total Expense Ratio | 0.77 | 2.38 | 32% |
Annual Report Gross Expense Ratio | 0.77 | 2.43 | 32% |
Fund Existence | 16 years | 25 years | - |
Gain YTD | 10.820 | 17.902 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.57B | 95.4M | 4,794% |
Annual Yield % from dividends | 0.38 | 0.00 | - |
Returns for 1 year | -6.51 | -12.20 | 53% |
Returns for 3 years | 23.91 | 3.28 | 729% |
Returns for 5 years | 10.48 | -34.72 | -30% |
Returns for 10 years | 41.23 | -33.98 | -121% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 143.46 | 0.79 | +0.55% |
Franklin Biotechnology Discovery C | |||
PAIGX | 23.04 | N/A | N/A |
T. Rowe Price International Value Eq Adv | |||
BGVCX | 34.75 | -0.07 | -0.20% |
Brandes Global Equity C | |||
NMSCX | 22.75 | -0.29 | -1.26% |
Columbia Small Cap Index Inst | |||
HSLTX | 49.38 | -0.81 | -1.61% |
Hartford Small Cap Growth R5 |